121
Participants
Start Date
January 21, 2020
Primary Completion Date
September 29, 2021
Study Completion Date
June 18, 2022
Injection of DESIRIAL®
"DESIRIAL® is a hyaluronic acid injectable gel intended to treat symptoms associated with vulvovaginal atrophy in postmenopausal women by vaginal mucosa rehydration in this study.~1 mL of DESIRIAL® will be injected in the vestibule and on the posterior and lateral walls of the vagina, 2 to 3 cm after the introitus."
Injection of placebo
"Placebo is an isotonic saline solution (0.9% NaCl).~1 mL of placebo will be injected in the vestibule and on the posterior and lateral walls of the vagina, 2 to 3 cm after the introitus."
Cabinet Dr Ali Bennani, Wavre
Gynaecologie Dr Deniz Gulcan, Meise
MIRHA, Zaventem
Gynecology private office, Antwerp
Gynaecologisch Centrum, Mechelen
Cabinet Gynécologie Obstétrique, Liège
Cabinet de gynécologie, Marseille
Cabinet de gynécologie, Toulouse
Clinique Georges V, Bordeaux
Cabinet de Gynécologie, Tarnos
Polyclinique de l'Atlantique, Saint-Herblain
CHRU Jeanne de Flandres, Lille
Cabinet de gynécologie, Perpignan
Cabinet de Gynécologie, Paris
Lead Sponsor
Laboratoires Vivacy
INDUSTRY